AstraZeneca to sell antibiotics business to Pfizer

August 24, 2016 6:15 AM

13 0

LONDON Pharmaceutical company AstraZeneca (AZN.L) said it had agreed to sell its small molecule antibiotics business to Pfizer (PFE.N) in a deal that could reach more than $1.5 billion.

The portfolio includes approved antibiotics Merrem, Zinforo and Zavicefta, and ATM-AVI and CXL, which are in clinical development, it said.

Also read: Russia's FG Budushchee rises in market debut

Read more

To category page